SCHEMBL5754262

SCHEMBL5754262

NC(=O)c1nccnc1N1CCCCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT2 Q8IXJ6 1/20 0.46
SIRT1 Q96EB6 1/20 0.46
SIRT3 Q9NTG7 1/20 0.46
PIM1 P11309 3/20 0.43
PIM3 Q86V86 3/20 0.43
PIM2 Q9P1W9 2/20 0.43
CYP1A2 P05177 3/20 0.41
CYP2C19 P33261 3/20 0.41
CYP2C9 P11712 2/20 0.41
NPC1 O15118 2/20 0.41
HCRTR1 O43613 1/20 0.41
HCRTR2 O43614 1/20 0.41
NEK2 P51955 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
CDK8 P49336 1/20 0.40
CYP3A4 P08684 1/20 0.40
PLAU P00749 3/20 0.40
ALDH1A1 P00352 3/20 0.39
SLC9A5 Q14940 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29546527 1.00 SIRT2 (0.46) SIRT2SIRT1SIRT3PIM1PIM3
SCHEMBL28145053 0.98 SIRT2 (0.43) SIRT2SIRT1SIRT3PIM1PIM3
SCHEMBL4060441 0.83 HTR2C (0.43) PIM1PIM3ALDH1A1KDM4E
SCHEMBL15733283 0.83 AURKA (0.47) CYP1A2CYP2C9HTTKDM4EGAA
SCHEMBL31687675 0.83 MEN1 (0.42) CYP1A2CYP2C19CYP2C9NEK2MEN1
SCHEMBL17859394 0.80 HCRTR1 (0.44) PIM1PIM3PIM2CYP1A2CYP2C19
SCHEMBL6600852 0.77 MAPK1 (0.44) SIRT2SIRT1SIRT3PIM1PIM3
SCHEMBL6600850 0.77 MAPK1 (0.44) SIRT2SIRT1SIRT3PIM1PIM3
SCHEMBL19566074 0.76 HCRTR1 (0.47) PIM1PIM3PIM2CYP1A2CYP2C19
SCHEMBL3891024 0.76 L3MBTL1 (0.43) PIM1PIM3PIM2CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104080769-B Aryl or heteroaryl substituted benzene compounds EPIZYME股份有限公司 2017-06-20 CN disclosed
EP-1638953-A1 3-SUBSTITUTED 5,6-DIARYL-PYRAZINE-2-CARBOXAMIDE AND -2-SULFONAMIDE DERIVATIVES AS CB1 MODULATORS AstraZeneca AB (SE) 2006-03-29 EP disclosed
WO-2004111034-A1 3-SUBSTITUTED 5,6-DIARYL-PYRAZINE-2-CARBOXAMIDE AND -2-SULFONAMIDE DERIVATIVES AS CB1 MODULATORS ASTRAZENECA AB (SE) 2004-12-23 WO disclosed